Effects of cysteamine, putrescine and cysteamine-putrescine combination on 3-Methylcholanthrene-induced fibrosarcoma in mice Farelerde 3-Metilkolantrenle i̇ndüklenen fibrosarkoma üzerine sisteamin, putresin ve sisteamin-putresin kombinasyonunun etkileri


Doǧan A., Aksu P., Erdaǧ D., ÖZCAN K., Doǧan E.

Kafkas Universitesi Veteriner Fakultesi Dergisi, cilt.20, sa.1, ss.11-17, 2014 (SCI-Expanded, Scopus, TRDizin) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.9775/kvfd.2013.9329
  • Dergi Adı: Kafkas Universitesi Veteriner Fakultesi Dergisi
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.11-17
  • Anahtar Kelimeler: 3-Methylcholanthrene, Cysteamine, Fibrosarcoma, Putrescine
  • Uşak Üniversitesi Adresli: Evet

Özet

In this study the effects of cysteamine, putrescine and the combination of cysteamine and putrescine were investigated in mice with 3-Methylcholanthrene (3-MC) induced on fibrosarcoma. A total of 135 adult male Mouse (Mus musculus) albino, 2-3 months old and weighting 20±2.0 g was used in this study. Mice in each group were divided 15 consisting of 9 individual. The first group was kept as a negative control group. The second group received subcutaneous injection of 0.2 ml sesame oil, and the third group was given subcutaneously 3-MC (1 mg/0.2 ml sesame oil). The 4th, 5th and 6th groups recived 0.1% cysteamine, 0.1% putrescine and 0.1% cysteamine + 0.1% putrescine mix with drinking water ad libitum respectively. The 7th, 8th and 9th groups were injected with 0.2 ml of 3-MC solution. After 1 month 0.1% cysteamine, 0.1% putrescine and 0.1% cysteamine + 0.1% putrescine combinations were administrated in drinking water to 7th, 8th and 9th groups respectively. After 1 year of all experiments mice tissues were evaluated morphologic and histopathologically. As a result were respectively demonstrated protective effect of putrescine, cysteamine+putrescine and cysteamin against 3-MC induced fibrosarcoma.